shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)

    RFA-NS-23-006

    National Institutes of Health

    Opening date 15 Sep 2022, 12:00AM

    Closing date 4 Apr 2025, 12:00AM

    Funding Opportunity Number: RFA-NS-23-006

    Opportunity Category: Discretionary

    CFDA Number(s): 93.213 -- Research and Training in Complementary and Integrative Health,93.233 -- National Center on Sleep Disorders Research,93.242 -- Mental Health Research Grants,93.273 -- Alcohol Research Programs,93.350 -- National Center for Advancing Translational Sciences,93.351 -- Research Infrastructure Programs,93.837 -- Cardiovascular Diseases Research,93.838 -- Lung Diseases Research,93.839 -- Blood Diseases and Resources Research,93.840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders,93.846 -- Arthritis, Musculoskeletal and Skin Diseases Research,93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders,93.859 -- Biomedical Research and Research Training,93.865 -- Child Health and Human Development Extramural Research,93.866 -- Aging Research

    Cost Sharing or Matching Requirement: No

    Posted Date: Sep 15, 2022 12:00:00 AM EDT

    Closing Date: Apr 04, 2025 12:00:00 AM EDT

    Award Ceiling: none

    Award Floor: none

    Eligible Applicants: Small businesses

    Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

    Agency Name: National Institutes of Health

    Description: The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.

    Grantor Contact Information: NIH Grants Information grantsinfo@nih.gov

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept